Harpoon Financial Statements From 2010 to 2024
| HARPDelisted Stock | USD 0.85 0.00 0.00% |
Check Harpoon Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harpoon Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Harpoon financial statements analysis is a perfect complement when working with Harpoon Therapeutics Valuation or Volatility modules.
Harpoon |
Harpoon Therapeutics Company Profit Margin Analysis
Harpoon Therapeutics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Harpoon Therapeutics Profit Margin | (0.82) % |
Most of Harpoon Therapeutics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Harpoon Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Harpoon Therapeutics has a Profit Margin of -0.8167%. This is 92.71% lower than that of the Biotechnology sector and 96.45% lower than that of the Health Care industry. The profit margin for all United States stocks is 35.69% lower than that of the firm.
Harpoon Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Harpoon Therapeutics's current stock value. Our valuation model uses many indicators to compare Harpoon Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Harpoon Therapeutics competition to find correlations between indicators driving Harpoon Therapeutics's intrinsic value. More Info.Harpoon Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Harpoon Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Harpoon Therapeutics Financial Statements
Harpoon Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Harpoon Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Harpoon Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Harpoon Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the bodys immune system to treat patients suffering from cancer and other diseases in the United States. Harpoon Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Harpoon Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.
Pair Trading with Harpoon Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Harpoon Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harpoon Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Harpoon Stock
| 0.71 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.56 | EC | Ecopetrol SA ADR | PairCorr |
| 0.54 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.53 | WF | Woori Financial Group | PairCorr |
| 0.5 | SHG | Shinhan Financial | PairCorr |
The ability to find closely correlated positions to Harpoon Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Harpoon Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Harpoon Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Harpoon Therapeutics to buy it.
The correlation of Harpoon Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Harpoon Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Harpoon Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Harpoon Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Harpoon Stock
If you are still planning to invest in Harpoon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Harpoon Therapeutics' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |